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Recovery of OCT findings after the treatment of AMD 
  Purpose: To evaluate whether the status of the external limiting membrane 
(ELM) or inner segment/outer segment junction (IS/OS) improves after 
intravitreal injection of ranibizumab for age-related macular degeneration (AMD). 
We also evaluated whether the pre-operative values of these parameters are 
associated with the visual prognosis. 
Methods: Hospital-based, cross-sectional study. 76 eyes of 76 treatment 
naïve AMD patients who received three monthly intravitreal injections of 
ranibizumab followed for more than six months with additional as-needed 
injections were investigated. Spectral domain OCT was used to evaluate the 
length of ELM, IS/OS, and foveal thickness pre- and post-operatively. Changes 
of ELM and IS/OS length were evaluated postoperatively. Correlation 
coefficients between pre-operative parameters and post-operative visual acuity 
were also analyzed. 
  Results: Significant changes were noted in mean logMAR (0.66 to 0.53), 
foveal thickness (231.1 to 151.1 μm), and IS/OS length (514.9 to 832.3 μm) after 
the treatment. ELM length did not improve significantly (1312.4 to 1376.7 μm). 
Although pre-operative ELM length, IS/OS length, and foveal thickness showed 
correlation with post-operative logMAR (R = -0.51, -0.39, and 0.46, respectively), 
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the most powerful predictive factor for visual prognosis was pre-operative 
logMAR (R = 0.77, P < 0.001). 
Conclusions: IS/OS status improves in response to anti-VEGF therapy but 
ELM seems to have less plasticity. Restoration of IS/OS occurs where ELM is 
retained. The status of IS/OS and ELM can be used as prognostic factors but the 
predictive power is inferior to that of baseline visual acuity. 
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Introduction 
Optical coherence tomography (OCT) is widely used to assess microstructural 
changes in the retina, especially that of macular pathologies.  Since the era of 
time-domain OCT, which had limited axial resolution of up to 10 μm, the device 
has been a standard tool in clinical practice[1] and in the management of 
age-related macular degeneration (AMD).[2-5]  Moreover, currently available 
spectral-domain OCT machines achieve up to 5-μm resolution and allow 
layer-by-layer evaluation of the retina.[6, 7] 
In AMD, photoreceptor integrity, as indicated by the retinal layer pattern, is 
important for vision.  Several groups have shown that continuity of the junction 
between inner and outer segments of the photoreceptors (IS/OS) is associated 
with good visual acuity (VA) in AMD patients who were treated with PDT[8] or 
with anti-VEGF agents. [9]  Another group used microperimetry and confirmed 
the association of IS/OS status and retinal sensitivity.[10]  Our group has 
reported that intact ELM as well as IS/OS is important for good vision. [11]  
Evaluation of these retinal changes provides detailed information and more 
profound understanding of retinal pathologies.[12], [13] 
The treatment of AMD drastically changed after two pivotal studies showed 
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marked effects of anti-vascular endothelial growth factor (VEGF) therapy.[14-16]  
The treatment enabled not only maintenance of vision but also improvement in 
patients with any subtype of AMD over a 24-month period.[14-16]  Although the 
relatively high cost of the drug and the need for ongoing intravitreal injections are 
demanding,[17] no other treatment has achieved these levels of visual acuity 
gain[18] and thus the treatment is now a first-line choice for AMD. 
Given the improvement in vision, it is clear that anti-VEGF therapy is beneficial 
for the retina.  However, how the therapy affects retinal microstructures such as 
IS/OS or ELM has not been evaluated.  Evaluation of these microstructures 
would provide more detailed information about the retinal changes during the 
treatment course and could help identify the potential for plasticity of these 
structures, i.e., how much photoreceptor damage could be recovered with the 
current standard treatment regimen.  In addition, if the morphologic changes 
during the treatment process are consistent, we may be able to predict visual 
prognosis from pre-operative findings because post-operative retinal 
morphology is associated with post-operative vision. [8, 9, 11] 
In the present study, we investigated quantitatively the changes of IS/OS and 
ELM after treatment.  We also examined pre-operative findings and visual 
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All procedures conformed to the tenets of the Declaration of Helsinki and the 
study design was approved by the institutional review board of Kobe City 
Medical Center General Hospital.  The review board waived the need for written 
informed consent because the study design consisted of retrospective chart 
review. 
We retrospectively reviewed the clinical records of patients who underwent three 
monthly injections of ranibizumab for AMD from February 2009 to February 2011 
and were followed for more than six months at Kobe City Medical Center 
General Hospital.  Diagnosis of AMD was made with funduscopy, slitlamp 
examination, OCT, and fluorescein / indocyaningreen angiography.  Patients 
who were under 50 years old or who had refractive error less than -6 diopters or 
axial length more than 26.5 mm were not considered as having AMD.  Only 
patients who were examined with SD-OCT before and after a follow-up period of 
more than six months were included in the study.  Exclusion criteria included 
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other retinal or optic nerve diseases such as retinal vein occlusion, diabetic 
retinopathy, or optic neuropathy.  Those who were previously treated with 
photodynamic therapy or laser photocoagulation and who dropped out from the 
treatment regimen were also excluded.  SD-OCT images were obtained with 
Spectralis: Spectralis Family Acquisition Module (version 4.0.2.0, Heidelberg 
Engineering, Dossenheim, Germany) with Heidelberg Eye Explorer (version 
1.6.1.0).  Horizontal scans of the macula were recorded for each eye.  The 
measurements were performed under pupillary dilation.  The eye tracking ART 
(automatic real time) software of the device was used to assure that the scans 
made were in the correct position and averagings were properly done; the 
position of the fovea was manually detected during examination.  We routinely 
averaged 60 scans per image and when the examination failed to average more 
than 40 images or to scan the foveola due to poor fixation or media opacity, the 
patients were excluded from the study. 
We measured the length of ELM and IS/OS within regions of 1 mm nasal and 
temporal from the fovea (Figure 1).  Measurement of ELM and IS/OS length 
was manually done using software built in the OCT.  To investigate the 
diagnostic value of qualitative evaluation, whether each line is continuous or 
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disrupted at fovea were also investigated.  Foveal thickness was defined as the 
distance between the vitreoretinal border and the edge of the retinal pigment 
epithelium.  When retinal detachment or sub-retinal fibrosis was seen, the inner 
border of the subretinal fluid or fibrosis was used as the outer boundary.  To 
evaluate the reproducibility and inter-examiner variability for the measurements, 
two independent examiners (A.O. and M.S.), who were masked as to the VA of 
the study participants, measured the above parameters and inter-observer 
variation was calculated.  The average of two measures was used for the 
statistical analysis.  In addition, images from 20 randomly selected patients 
were re-measured by the same examiner (M.S.) two months after the first 
measurement and intra-observer variability was calculated. Clinical 
characteristics, including age, sex, and angiographic classification: occult with 
no classic, minimally classic, and predominantly classic were also reviewed and 
analyzed. To detect maximal changes after the treatment, the image with least 
exudative changes was selected for each patient and evaluated as the 
post-operative image. Selection of the images with least exudative changes was 
done by two of the authors (A.O. and M.S.) and always coincided. 
Statistical analysis was performed using IBM SPSS Statistics Desktop (version 
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19.0.0; IBM Japan, Tokyo, Japan). Descriptive analyses are reported as means 
± standard deviation unless otherwise specified. Visual acuities were measured 
with a Landolt C chart and then converted to logarithm of the minimum angle of 
resolution (logMAR) equivalents. Bivariate relationships were examined using 
Spearman’s rank correlation coefficient. Intra and inter examiner variability was 
tested using intraclass correlation coefficients ICC(1,1) and ICC(2,1), 
respectively.  Group means for each measurement were compared using 
one-way analysis of variance (ANOVA) with Bonferroni correction. P values of 
less than 0.05 were considered to be statistically significant. 
Results 
 We reviewed 144 eyes of 144 patients who were planned to undergo 
three monthly induction and as-needed additional treatment.  After the 
exclusion of 11 patients with poor quality image, 45 patients with previous 
treatment, and 12 patients who dropped out from the treatment regimen, a total 
of 76 eyes of 76 patients with AMD met the inclusion criteria. The mean age of 
the enrolled patients was 77.3 ± 9.6 years; there were 45 men and 31 women. 
Pre-operative logMAR was 0.67 ± 0.41.  Thirty-four eyes were classified as 
occult with no classic, 17 as minimally classic, and 25 as predominantly classic.  
9 
 
Recovery of OCT findings after the treatment of AMD 
Foveal thickness was 231.1 ± 136.2 μm. The ELM length was 1312.4 ± 660.3 
μm and the IS/OS length was 514.9 ± 574.2 μm.  The inter-examiner 
measurements were highly correlated; intraclass correlation coefficients 
between the measurements by two of the authors were 0.84 for ELM and 0.89 
for IS/OS.  Intra-examiner correlation coefficients were 0.85 for ELM and 0.93 
for IS/OS. 
IS/OS was disrupted at fovea in 56 cases and ELM in 30 cases.  Disruption of 
each line at fovea was associated with poor logMAR (0.76 ± 0.40 in IS/OS 
disrupted and 0.39 ± 0.31 in IS/OS continuous cases, P<0.001; 0.92 ± 0.41 in 
ELM disrupted and 0.49 ± 0.31 in ELM continuous cases, P<0.001) ELM was 
almost always (74 of 76 cases) longer than IS/OS; when IS/OS was preserved, 
they were almost always accompanied by ELM.  Those with occult with no 
classic lesion had longer ELM (1580.6 ± 516.9 μm) and IS/OS (677.3 ± 646.2 
μm) compared to those with minimally classic lesion (ELM:1115.3 ± 657.8 μm, 
P=0.04; IS/OS:258.1 ± 422.2 μm, P=0.04) or predominantly classic lesion 
(ELM:1081.7 ± 722.4 μm, P=0.01; IS/OS:468.7 ± 501.0 μm, P=0.48) 
The participants underwent 4.2 ± 1.2 intravitreal injections during the observation 
period of 7.7 ± 1.9 months.  LogMAR improved to 0.53 ± 0.41.  Foveal 
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thickness decreased to 151.1 ± 48.5 μm, P<0.001, probably reflecting the 
resolution of retinal edema.[19](Figure 2)  IS/OS length increased to 832.3 ± 
743.3 μm, P<0.001.  In other words, the IS/OS recovered approximately 60% of 
its continuity.(Figure 3)  On the other hand, post-operative ELM length was 
1376.7 ± 654.6 μm and was not significantly different from pre-operative 
measurements.  There was no significant difference in ELM and IS/OS 
improvements (post-operative length minus pre-operative length) among occult 
and classic lesions.  Foveal disruption of IS/OS (n=46) and ELM (n=26) was 
again associated with visual acuity (0.74 ± 0.37 in IS/OS disrupted and 0.21 ± 
0.21 in IS/OS continuous cases, P<0.001; 0.94 ± 0.34 in ELM disrupted and 0.31 
± 0.25 in ELM continuous cases, P<0.001).  Pre-operative or post-operative 
foveal disruption of ELM or IS/OS made no difference in ELM or IS/OS 
improvement. 
Since the mean ELM length did not show significant changes, we further 
assessed the status of the ELM in individual cases.  We reviewed the images of 
19 eyes that showed more than 300-μm improvement of the ELM (based on the 
standard deviation SD of the difference between the two observers: 289.9 μm). 
These cases, in the pre-operative state, typically showed abnormalities in the 
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outer retina that could complicate the interpretation (Figure 4).  In fact, 12 cases 
had subretinal fibrin like material, 4 cases had CME, 2 cases had subretinal 
fibrovascular lesion, and 2 cases had accumulation of exudates (some cases 
had combinations of these).  We cannot tell whether the ELM had defects or if 
the ELM was only invisible due to these masking factors in these cases. 
We also investigated 38 eyes, which showed more than 300-μm IS/OS 
restoration.  Fibirin, CME, subretinal fibrovascular lesion, and/or accumulation 
of exudates were also noted in these eyes (16, 10, 2, and 6 eyes, respectively).  
The influences of these masking factors were again suspected in these cases.  
In addition, IS/OS restoration was observed only in area where ELM existed 
post-operatively but pre-operative ELM preservation was not a pre-requisite for 
IS/OS recovery. 
We then assessed the prognostic value of these parameters.  Pre-operative 
foveal thickness, ELM length, and IS/OS length were associated with 
post-operative logMAR (R = 0.46, P < 0.001; R = -0.51, P < 0.001; R = -0.39, P = 
0.001; respectively).  However, pre-operative logMAR showed a stronger 
correlation (R = 0.77, P < 0.001).  When we performed a multiple 
linear-regression analysis, factors other than pre-operative logMAR did not show 
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significant effects on post-operative logMAR.  The adjusted R2 for the model 
was 0.59; the standardized regression coefficient of pre-operative logMAR was 
0.77, P < 0.001. 
Discussion 
We evaluated the changes of OCT-depicted retinal structures, especially ELM 
and IS/OS, after anti-VEGF therapy.  The results indicated that the IS/OS 
improves in response to the treatment; however, ELM has less plasticity.  The 
study also showed the prognostic potential of these factors, although the 
predictive power seemed inferior to that of pre-operative visual acuity. 
Anti-VEGF therapy is now a first-line treatment for AMD.[20]  With the treatment 
regimen, retinal thickness improved and some of the IS/OS disturbance 
recovered.  The plastic capacity of the IS/OS is plausible considering that outer 
segments reproduce daily and it takes less than 10 days for complete 
renewal.[21]  In addition, the recovery of IS/OS always occurred where ELM 
existed.  The finding confirms the notion that healthy photoreceptor is needed 
to produce outer segments and presence of ELM can be an indicator of 
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On the other hand, ELM seemed to have limited plasticity; ELM length did not 
change significantly and false-positive effects were frequently suspected in the 
individual cases where ELM improved.  The result suggested that ELM 
disruption indicates more severe damage to photoreceptor cell bodies and it 
should be more difficult, if possible as we reported in closed MH [22], to 
overcome. Given that we do not have a way to directly regenerate the damaged 
retina, treatment should be as early as possible to avoid irreversible changes in 
the photoreceptors. 
Predicting the visual prognosis from pre-operative OCT findings is of clinical 
interest in the management of AMD.[23-26]  In the present study, foveal 
disruption of each line was associated with visual acuity in pre-operative or 
post-operative state in consistent with the previous reports. [8-11] In addition, we 
showed that foveal thickness, length of ELM, and length of IS/OS have 
prognostic value for vision. However, pre-operative visual acuity showed 
stronger correlation with visual prognosis, consistent with the previous notion 
that OCT or angiography alone does not offer sufficient prediction of 
function.[27]  The result from the present multiple regression analysis 
suggested that pre-operative OCT findings are confounding factors of 
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pre-operative logMAR.  Thus, although we can roughly predict visual prognosis 
from OCT findings, checking pre-operative visual acuity seems to be the most 
efficient way at present.  Some modifications including refinement of image 
resolution[28] or combination of parameters would be needed for practical use. 
There are several limitations to the present study including the retrospective 
study design, a relatively small population from a single institution, and the use 
of the Landolt C chart for VA measurement rather than the ETDRS chart used in 
major clinical trials.  Another limitation is the very nature of OCT examinations. 
The device depicts only a difference in light reflectance. Thus, disturbance of the 
ELM or IS/OS detected in OCT images does not necessarily indicate the 
disturbance of photoreceptors in a histopathologic context.  We should keep in 
mind that these features are just parameters and not necessarily anatomic 
changes.  Clinical relevance and histologic interpretation of the findings should 
be considered differently. 
Additionally, there were difficulties in manual measurement of ELM or IS/OS 
length.  When compared to more orderly images as seen in epiretinal 
membrane (ERM) or macular hole (MH), AMD-affected retinas often were 
accompanied by fibrin, hemorrhage, or hard exudates, which make the 
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interpretation of retinal structures difficult.  The improvement of these lines can 
be a result of better visualization rather than histologic recovery.  In addition, 
the images are often not in alignment due to subretinal fluid or hemorrhage.  
Although we confirmed the inter- and intra-observer reproducibility of the results, 
measurements were less consistent when compared to our previous experience 
dealing with ERM[29] or MH.[22]   
Finally, we have shown that the IS/OS improves in response to treatment but 
ELM has less plasticity.  The result warrants further investigations for treatment 
strategies to enable ELM recovery.  We have also shown the prognostic value 
of OCT parameters for visual outcome although the predictive power seemed 
inferior to that of initial visual acuity. Further development in the resolution of 
OCT images, identification of other factors, and/or a combination of the factors is 
needed to enhance this prognostic value. 
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Optical coherence tomography images of a patient with age-related macular 
degeneration demonstrating how the measurements were performed in the 
study. Length of External limiting membrane (ELM) and inner segment / outer 
segment junction (IS/OS) was measured along with each line as closely as 
possible using a caliper tool within a region 1 mm temporal and nasal from the 
fovea. In the presented case, both lines were disturbed where subretinal 
hemorrhage and fibrin existed (asterisk) and exact measurements were as 
follows ELM: from left to right 448, 224, 638, and 365 μm IS/OS: 400, 225, 515, 
72, and 352 μm. 
Figure 2 
Pre- and post-operative changes in each parameter. Left: Foveal thickness 
decreased by approximately 30% and the change was statistically significant. 
Right: While IS/OS recovered its continuity, the ELM length did not show 
significant improvement. * indicates P<0.001 
Figure 3 
Pre- (upper) and post- (lower) operative OCT images of a representative case 
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that showed improvement of IS/OS length. In the pre-operative image, IS/OS 
(arrow) was disturbed where intraretinal fluid accumulated. The post-operative 
image showed improvement of IS/OS, which was almost complete within 1 mm 
region from fovea. 
Figure 4 
Pre- (upper) and post- (lower) operative OCT images of a representative case 
that showed improvement of ELM length. Note the accumulation of subretinal 
fibrin and hard exudate in the pre-operative image (asterisk). ELM (triangle) was 
confirmed outside the deposits but is obscured in the central fovea where fibrin 
infiltrates into the outer retina. The post-operative image showed almost intact 
ELM in the depicted area. IS/OS was also improved in this case. We cannot tell 
whether the change represented the improvement of ELM or the removal of a 
signal-masking effect. 
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